It is noteworthy that when this approach is combined with conventional chemotherapy, IFN-β contributes to anti-tumor activity by inducing apoptosis and inhibiting cell proliferation, while cisplatin primarily causes DNA damage, leading to cell death. The gene discussed is IFNB1; the disease is neoplasm.